All data are based on the daily closing price as of December 15, 2025
c
Chong Kun Dang Pharmaceutical
185750.KO
58.98 USD
-0.55
-0.92%
Overview
Last close
58.98 usd
Market cap
777.06M usd
52 week high
90.07 usd
52 week low
48.18 usd
Target price
76.95 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
0.6811
Price/Book Value
1.2285
Enterprise Value
840.64M usd
EV/Revenue
0.7335
EV/EBITDA
11.0927
Key financials
Revenue TTM
1.15B usd
Gross Profit TTM
358.92M usd
EBITDA TTM
73.44M usd
Earnings per Share
N/A usd
Dividend
0.75 usd
Total assets
1.09B usd
Net debt
58.95M usd
About
Chong Kun Dang Pharmaceutical Corp. engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally. The company provides prescription drugs for anti-hypertension, anti-hyperlipidemia, anti-diabetics, and immunosuppressants; over-the-counter medicine comprising headache remedies, dewormers, digestive aids, and vitamins; probiotics and Omega-3 supplements; and health drinks, hair dyes, and insecticides. It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea.